Meeting
2023 ASCO Annual Meeting
Utility of multi-gene panel-based germline analysis following genomic profiling and cascade testing in advanced solid tumors: An initial report of the BRANCH study.
Authors
Takeshi Kuwata
National Cancer Center Hospital East, Kashiwa-Shi, Japan
Takeshi Kuwata , Yoshiaki Nakamura , Tomohiro Nishina , Naoki Takahashi , Hiroto Narimatsu , Hourin Cho , Chiaki Inagaki , Shigenori Kadowaki , Yoshinaga Okugawa , Sawako Matsuzaki , Naohiro Tomita , Hisateru Yasui , Yu Sunakawa , Manami Matsukawa , Kaori Kimura , Yumie Hiraoka , Makoto Hirata , Issei Imoto , Shinji Kosugi , Takayuki Yoshino
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Prevention, Risk Reduction, and Hereditary Cancer
Track
Prevention, Risk Reduction, and Genetics
Sub Track
Germline Genetic Testing
Clinical Trial Registration Number
UMIN000046085
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 10615)
DOI
10.1200/JCO.2023.41.16_suppl.10615
Abstract #
10615
Poster Bd #
248
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Spectrum of germline pathogenic variants among patients with cancer in Mexico.
First Author: Jose Luis Rodriguez Olivares
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Pathogenic variants among Mexican patients with colorectal cancer referred for genetic cancer risk assessment.
First Author: Jose Luis Rodriguez Olivares
Poster
2019 ASCO Annual Meeting
Germline multigene panel testing in colorectal cancer: Precision therapy and clinical management implications.
First Author: Edward D. Esplin
First Author: Lixi Li